JMP Group Inc (JMP)

7.5  +0.02 (+0.27%)

After market: 7.49 -0.01 (-0.13%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to JMP. JMP was compared to 210 industry peers in the Capital Markets industry. JMP has a bad profitability rating. Also its financial health evaluation is rather negative. JMP is not overvalued while it is showing excellent growth. This is an interesting combination.



0

1. Profitability

1.1 Basic Checks

In the past year JMP was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 4.71%
ROE 15.12%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 9.63%
PM (TTM) 6.1%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

JMP has more shares outstanding than it did 1 year ago.
The debt/assets ratio for JMP has been reduced compared to a year ago.

2.2 Solvency

JMP has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

7

3. Growth

3.1 Past

JMP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9800.00%, which is quite impressive.
JMP shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.33% yearly.
Looking at the last year, JMP shows a very strong growth in Revenue. The Revenue has grown by 99.21%.
Measured over the past years, JMP shows a decrease in Revenue. The Revenue has been decreasing by -6.66% on average per year.
EPS 1Y (TTM)9800%
EPS 3Y-3.03%
EPS 5Y-6.33%
EPS growth Q2Q123.08%
Revenue 1Y (TTM)99.21%
Revenue growth 3Y-7.62%
Revenue growth 5Y-6.66%
Revenue growth Q2Q58.42%

3.2 Future

The Earnings Per Share is expected to grow by 30.69% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 29.95% on average over the next years. This is a very strong growth
EPS Next Y35.21%
EPS Next 2Y6.79%
EPS Next 3Y21.98%
EPS Next 5Y30.69%
Revenue Next Year65.99%
Revenue Next 2Y28.13%
Revenue Next 3Y29.13%
Revenue Next 5Y29.95%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.58 indicates a rather cheap valuation of JMP.
The average S&P500 Price/Earnings ratio is at 24.92. JMP is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 10.61, the valuation of JMP can be described as very reasonable.
When comparing the Price/Forward Earnings ratio of JMP to the average of the S&P500 Index (21.49), we can say JMP is valued rather cheaply.
Industry RankSector Rank
PE 7.58
Fwd PE 10.61

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.18

4.3 Compensation for Growth

JMP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
JMP's earnings are expected to grow with 21.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y6.79%
EPS Next 3Y21.98%

0

5. Dividend

5.1 Amount

No dividends for JMP!.
Industry RankSector Rank
Dividend Yield 0%

JMP Group Inc

NYSE:JMP (11/15/2021, 7:51:24 PM)

After market: 7.49 -0.01 (-0.13%)

7.5

+0.02 (+0.27%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap157.82M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 7.58
Fwd PE 10.61
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.22
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.71%
ROE 15.12%
ROCE
ROIC
ROICexc
ROICexgc
OM 9.63%
PM (TTM) 6.1%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)9800%
EPS 3Y-3.03%
EPS 5Y
EPS growth Q2Q
EPS Next Y35.21%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)99.21%
Revenue growth 3Y-7.62%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y